Showing results (291-300 of 314) with videos related to

Sort By:
Pageof 32
European Urology|September 13, 2025
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi AnalysisKen Herrmann, Jochen Walz, Steven MacLennan, et al.
The Journal of Urology|May 11, 2019
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic ApproachesPaolo Gontero, Giancarlo Marra, Paolo Alessio, et al.
The Lancet. Oncology|July 5, 2025
First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 studyJames P Buteau, Louise Kostos, Price A Jackson, et al.
European Urology|January 4, 2022
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy StrategyPeter-Paul M Willemse, Niall F Davis, Nikolaos Grivas, et al.
The Lancet. Oncology|June 10, 2026
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trialJames P Buteau, Daniel Moon, Michael T Fahey, et al.
The American Journal of Psychiatry|March 1, 2014
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion SyndromeMaude Schneider, Martin Debbané, Anne S Bassett, et al.
BJU International|June 10, 2026
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomyEdoardo Beatrici, Mario de Angelis, Ricardo Almeida-Magana, et al.
BJU International|November 13, 2020
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statementZafer Tandogdu, Justin Collins, Greg Shaw, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
Nature Medicine|November 10, 2020
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndromeRobert W Davies, Ania M Fiksinski, Elemi J Breetvelt, et al.
Pageof 32